Diagnosis
IBS is a clinical diagnosis based on recurrent abdominal pain related to defecation and associated with a change in stool frequency or form, using symptom-based Rome criteria, in the absence of features suggesting organic disease. It is a positive diagnosis rather than one of exclusion, though limited testing is used to rule out mimics. The pathophysiology involves altered gut motility, visceral hypersensitivity, and the gut-brain axis.
Subtypes
IBS is classified by the predominant bowel pattern: IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and mixed type (IBS-M). Classifying the subtype matters because it directs treatment. Symptoms are typically chronic and relapsing, often worsened by stress and certain foods, and relieved in part by defecation.
Alarm Features
Certain "red flag" features argue against IBS and mandate investigation for organic disease such as inflammatory bowel disease or malignancy: rectal bleeding, unintentional weight loss, iron-deficiency anemia, nocturnal symptoms, a family history of colorectal cancer or IBD, and new onset after age 50. Their absence supports a confident clinical diagnosis of IBS.
Management
Treatment is directed at symptoms and begins with education, reassurance, dietary modification (including a low-FODMAP trial), and soluble fiber. Medications are chosen by subtype: antispasmodics and loperamide or bile-acid modifiers for diarrhea, and osmotic laxatives or secretagogues for constipation. Low-dose antidepressants (TCAs or SSRIs) help pain and the gut-brain component in some patients.